Principal Investigator — Internal Medicine
Mayelin Amoros Duquesne, MD, MHA
Board-certified internist and hospitalist with broad inpatient and outpatient experience across internal medicine, pulmonology, cardiology, infectious disease, and pain management, applied to industry-sponsored clinical research.
Profile
Dr. Amoros Duquesne joined Salud Clinical Services in January 2025 and serves as Principal Investigator. She completed her ACGME internal medicine residency at San Juan City Hospital in Puerto Rico and holds a Master of Healthcare Administration alongside her medical degree.
Her clinical background spans complex hospital medicine and outpatient care for patients from diverse economic and cultural backgrounds, which supports a multidisciplinary approach to protocol conduct and participant safety.
- Profile
- Internal Medicine
- At Salud since
- 2025
- Languages
- English and Spanish (fluent, written and verbal)
Education and training
- Internal Medicine Residency (ACGME) — San Juan City Hospital, San Juan, PR, 2018–2021
- Hospitalist Internship — Hospitals HIMA, Caguas, PR, 2016–2017
- Doctor of Medicine — University of Medicine & Health Sciences, St. Kitts & Nevis, 2016
- Physician Assistant, Outpatient Cardiology / Internal Medicine — Caribbean Heart Institute, Caguas, PR, 2016
- Master of Healthcare Administration — Walden University, Minneapolis, MN, 2015
- B.Sc. Human Biology — University of Toronto, Canada, 2006
Licenses and certifications
- Florida State Medical License
- Federal Narcotics Medical License (DEA)
- Internal Medicine Board Certified
- ACLS and BLS Certified
- ECFMG certified (2017)
- Hospitalist Internship Certification
Professional experience
- Salud Clinical Services — 2025–Present
- Vitas Healthcare, Inpatient Unit Physician — 2024–Present
- HCA FL Lawnwood, Locums Nocturnist — 2024–Present
- Lee Health, Hospital Medicine, Fort Myers, FL — 2021–2023
- IMOS Hospitalist Group, Hospitals HIMA, Caguas, PR — 2020–2021
Professional organizations
- American College of Physicians
- American Medical Association
- Florida Medical Association
Clinical research experience
| Study focus | Phase | Sponsor | Years |
|---|---|---|---|
| COPD and chronic bronchitis, add-on to maintenance triple therapy | Phase 3 | Chiesi | 2021–2024 |
| Early COVID-19 treatment | Phase 2 | SyneuRx International | 2021–2022 |
| Cardiovascular risk reduction in statin intolerance | Phase 3 | Esperion Therapeutics | 2021 |
| Alinity m HR HPV sample collection | Observational | Abbott Molecular | 2021–2022 |
| COVISTIX in vitro diagnostics clinical performance | Diagnostic | Sorrento Therapeutics | 2021–2022 |
| Moderate to severe osteoarthritis pain of the knee | Phase 2 | Biosplice Therapeutics | 2022 |
| COPD triple and dual combination therapies | Phase 3 | Chiesi | 2022–2024 |
| Tiotropium bromide inhalation powder 18 µg bioequivalence | Phase 3 | Xiromed | 2022–2023 |
| Safety and immunogenicity of a COVID-19 vaccine booster dose | Phase 2/3 | Novavax | 2023 |
| Primary prevention of atherosclerotic cardiovascular disease | Phase 3 | Novartis | 2023–Present |
| Moderate to severe atopic dermatitis | Phase 2 | AnaptysBio | 2024 |
| Non-cystic fibrosis bronchiectasis with chronic Pseudomonas aeruginosa infection | Phase 2 | Armata Pharmaceuticals | 2024 |
Frequently asked questions
Answers to questions we hear most often.
What is a Principal Investigator?
The Principal Investigator is the qualified clinician responsible for conducting the study at the site, protecting participant safety, and ensuring the protocol is followed.
Who will I see at my study visits?
Most visits are conducted by a clinical research coordinator, with the Principal Investigator or a sub-investigator involved in medical assessments and safety review.
Is the research staff trained in Good Clinical Practice?
Yes. GCP and protocol-specific training is completed and documented before staff are delegated study responsibilities.
Can I request a Spanish-speaking coordinator?
Yes. Our team is bilingual and visits can be conducted in English or Spanish.
Information on this website is provided for general educational purposes about clinical research and is not medical advice. Participation in any study is voluntary.